Announced
Completed
Eight Roads Ventures, F-Prime Capital completed the acquisition of a 8% stake in Enzene Biosciences for $20m.
Synopsis
Private equity firms Eight Roads Ventures, F-Prime Capital completed the acquisition of a 8% stake in Enzene Biosciences, a biotechnology company, for $20m.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.